Improvement of TNBC immune checkpoint blockade with a microwave-controlled ozone release nanosystem-Reference-Cited by-同舟云学术

Improvement of TNBC immune checkpoint blockade with a microwave-controlled ozone release nanosystem

Published:2022-11 Issue: Volume:351 Page:954-969
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Song Linlin,Zheng Dan,Xu Jinshun,Xu Tianyue,Liu Zhihui,Zhang Huan,Li Yi,Peng Yulan,Shi Hubing

Funder

Sichuan University

Shaoxing Bureau of Science and Technology

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference52 articles.

1. Insights into molecular classifications of triple-negative breast cancer: improving patient selection for treatment;Garrido-Castro;Cancer Discov.,2019

2. Treatment landscape of triple-negative breast cancer - expanded options, evolving needs;Bianchini;Nat. Rev. Clin. Oncol.,2022

3. PSMG2-controlled proteasome-autophagy balance mediates the tolerance for MEK-targeted therapy in triple-negative breast cancer;Wang;Cell Rep. Med.,2022

4. Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98;Loi;J. Clin. Oncol.,2013

5. PD-L1 expression correlates with tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy in breast cancer;Wimberly;Cancer Immunol. Res.,2015

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Boosting TNBC immune checkpoint blockade with an imaging-therapy coupled ozone delivery nano system;Chemical Engineering Journal;2024-09

2. Biomimetic MOF‐Based Nano‐Immunoactivator via Disruption of Ion Homeostasis for Strengthened Tumor Microwave‐Immunotherapy;Advanced Functional Materials;2024-03-04

3. Ozone Therapy for Breast Cancer: An Integrative Literature Review;Integrative Cancer Therapies;2024-01

4. Advances in immunotherapy for triple-negative breast cancer;Molecular Cancer;2023-09-02